As the Biocatalysis Development Chemist you will report directly to the Head of Innovation.
The main purpose of your role will be to develop and demonstrate new biocatalysis processes in the laboratory and translate those processes into ones which are capable of running within the Sterling's assets at the appropriate scale.
At Sterling, we deliver an exceptional experience to our customers, one that has scientific partnership at its core.
We offer a competitive compensation and benefits package including bonus, pension scheme, private healthcare, Perkbox, cycle to work scheme, death in service coverage, on-site health and wellbeing support including medical consultations and physiotherapy, 24/7 employee assistance programme, employee referral scheme, sports and social club as well as opportunity for training and further career development.
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years' experience in developing and manufacturing Active Pharmaceutical Ingredients (APIs). This is complemented by Antibody Drug Conjugate (ADC) research and development bioconjugation services.
We are a fast growing, dynamic business with facilities in the UK and the US, where we employ more than 800 talented and passionate people who support our customers in bringing new medicines to market, improving and saving the lives of patients.
Our culture and our way of working is what really sets us apart as a business; we aim to deliver an exceptional experience to our customers and our employees. You can expect to be part of a supportive team, all working towards a shared goal: to deliver first-class science and service to our customers every day.
We've signed the Gradcracker feedback pledge.
(This means that we will supply feedback if requested after an interview.)
1e127ede32d8f816eacfb0aed73cee11